Hinge Health (NYSE:HNGE) Now Covered by Analysts at KeyCorp

Investment analysts at KeyCorp began coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a report issued on Monday,Benzinga reports. The firm set an "overweight" rating and a $45.00 price target on the stock. KeyCorp's target price suggests a potential upside of 29.46% from the stock's current price.

HNGE has been the subject of a number of other reports. Wall Street Zen upgraded Hinge Health to a "hold" rating in a research note on Monday, June 2nd. Barclays initiated coverage on shares of Hinge Health in a research report on Monday. They set an "overweight" rating and a $43.00 target price for the company. Finally, Canaccord Genuity Group assumed coverage on shares of Hinge Health in a research report on Monday. They issued a "buy" rating and a $52.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $46.75.

Hinge Health Trading Down 0.7%

Shares of HNGE opened at $34.76 on Monday. Hinge Health has a one year low of $33.42 and a one year high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.